Fundus Image-guided Focal Electroretinography, Usability Study
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to investigate the usability of fundus image-guided focal electroretinography device with healthy subjects and with macular edema and macular degeneration patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2021
CompletedFirst Posted
Study publicly available on registry
October 29, 2021
CompletedStudy Start
First participant enrolled
November 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 25, 2022
CompletedNovember 8, 2022
November 1, 2021
10 months
October 6, 2021
November 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Signal-to-noise ratio of focal electroretinography signal
Signal-to-noise ratio of the focal ERG signals with different ERG electrodes.
Through study completion, an average of 1 year
Focal ERG from symptomatic retinal area
Explore the device feasibility in recording focal ERG signal from areas with macular edema or macular degeneration.
Through study completion, an average of 1 year
Secondary Outcomes (1)
Patient comfort and usability of different ERG electrodes in focal ERG.
Through study completion, an average of 1 year
Study Arms (2)
Phase I, healthy subjects
EXPERIMENTALGeneral usability of the device is tested with healthy patients. Different commercial electroretinography electrodes are tested to investigate the patient comfort, usability and signal-to-noise ratio when recording fundus image-guided focal electroretinography with the investigational device. Most suitable electrode is selected to phase II.
Phase II, patients with macular edema or macular degeneration
EXPERIMENTALThe usability of the device is tested with patients suffering either from macular edema or macular degeneration. Fundus image-guided focal electroretinography is recorded with the electrode chosen in phase I from two different retinal areas: from an area with macular edema or signs of macular degeneration and from a healthy area (area without macular edema or signs of macular degeneration).
Interventions
Investigate the patient comfort, usability and signal-to-noise ratio of different commercial CE marked ERG electrodes.
Record focal ERG from a healthy retinal area and from an area with visible symptoms.
Eligibility Criteria
You may qualify if:
- Healthy volunteers with no signs of macular edema or macular degeneration (phase I)
- Patients with either macular edema or macular degeneration (phase II)
- Able to give informed consent
You may not qualify if:
- Epileptic patients
- Vulnerable population: pregnant and breastfeeding women, underage, prisoners, persons with physical handicaps or mental disabilities, and disadvantaged persons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maculaser Oylead
Study Sites (1)
Helsinki University Hospital, Retinal Outpatient Clinic
Helsinki, Uusimaa, 00280, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joni Turunen, MD
Helsinki University Central Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2021
First Posted
October 29, 2021
Study Start
November 4, 2021
Primary Completion
August 25, 2022
Study Completion
August 25, 2022
Last Updated
November 8, 2022
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share